Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
American Journal of Physiology. Endocrinology and Metabolism
|
November 16, 2017
Insulin secretory effect of sitagliptin: assessment with a hyperglycemic clamp combined with a meal challenge
Sudha S Shankar, R Ravi Shankar, Lori A Mixson, et al.
Journal of Hepatology
|
June 24, 2023
A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease
Manuel Romero-Gómez, Eric Lawitz, R Ravi Shankar, et al.
Journal of Diabetes Investigation
|
October 15, 2016
Sitagliptin added to stable insulin therapy with or without metformin in Chinese patients with type 2 diabetes
R Ravi Shankar, Yuqian Bao, Ping Han, et al.
Reproductive Biology and Endocrinology : RB&E
|
March 9, 2017
An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism
Eberhard Nieschlag, Pierre-Marc G Bouloux, Barbara J Stegmann, et al.
Current Medical Research and Opinion
|
May 27, 2017
A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
R Ravi Shankar, Silvio E Inzucchi, Victoria Scarabello, et al.
Pediatric Diabetes
|
May 16, 2018
Changes in diabetes medication regimens and glycemic control in adolescents and young adults with youth-onset type 2 diabetes: The SEARCH for diabetes in youth study
Cathy A Pinto, Jeanette M Stafford, Tongtong Wang, et al.
Diabetes, Obesity & Metabolism
|
September 5, 2018
Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin
Miao Yu, R Ravi Shankar, Ruya Zhang, et al.
Journal of Diabetes
|
August 10, 2016
Randomized trial assessing the safety and efficacy of sitagliptin in Chinese patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea alone or combined with metformin
Jianming Ba, Ping Han, Guoyue Yuan, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 31, 2015
A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Co-Administration of Sitagliptin with Intensively Titrated Insulin Glargine
Chantal Mathieu, R Ravi Shankar, Daniel Lorber, et al.
Diabetes Research and Clinical Practice
|
October 29, 2017
A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes
Philip Home, R Ravi Shankar, Ira Gantz, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
American Journal of Physiology. Endocrinology and Metabolism
|
November 16, 2017
Insulin secretory effect of sitagliptin: assessment with a hyperglycemic clamp combined with a meal challenge
Sudha S Shankar, R Ravi Shankar, Lori A Mixson, et al.
Journal of Hepatology
|
June 24, 2023
A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease
Manuel Romero-Gómez, Eric Lawitz, R Ravi Shankar, et al.
Journal of Diabetes Investigation
|
October 15, 2016
Sitagliptin added to stable insulin therapy with or without metformin in Chinese patients with type 2 diabetes
R Ravi Shankar, Yuqian Bao, Ping Han, et al.
Reproductive Biology and Endocrinology : RB&E
|
March 9, 2017
An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism
Eberhard Nieschlag, Pierre-Marc G Bouloux, Barbara J Stegmann, et al.
Current Medical Research and Opinion
|
May 27, 2017
A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
R Ravi Shankar, Silvio E Inzucchi, Victoria Scarabello, et al.
Pediatric Diabetes
|
May 16, 2018
Changes in diabetes medication regimens and glycemic control in adolescents and young adults with youth-onset type 2 diabetes: The SEARCH for diabetes in youth study
Cathy A Pinto, Jeanette M Stafford, Tongtong Wang, et al.
Diabetes, Obesity & Metabolism
|
September 5, 2018
Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin
Miao Yu, R Ravi Shankar, Ruya Zhang, et al.
Journal of Diabetes
|
August 10, 2016
Randomized trial assessing the safety and efficacy of sitagliptin in Chinese patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea alone or combined with metformin
Jianming Ba, Ping Han, Guoyue Yuan, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 31, 2015
A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Co-Administration of Sitagliptin with Intensively Titrated Insulin Glargine
Chantal Mathieu, R Ravi Shankar, Daniel Lorber, et al.
Diabetes Research and Clinical Practice
|
October 29, 2017
A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes
Philip Home, R Ravi Shankar, Ira Gantz, et al.
Page
of 5